Experiment 950334

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationSESSA,C: ZUCCHETTI,M: DAVOLI,E: CALIFANO,R: CAVALLI,F: FRUSTACI,S: GUMBRELL,L: SULKES,A: WINOGRAD,B: D'INCALCI,M:. (1991). PHASE I AND CLINICAL PHARMACOLOGICAL EVALUATION OF APHIDICOLIN GLYCINATE.. 83(16)
Amount utilized
Compound isolated
Disease24 PATIENTS WERE ENTERED IN A PHASE I STUDY. DAILY DOSES OF 12-2250 MG/SQ M WERE GIVEN FOR 5 DAYS EVERY 3 WEEKS. DOSE-RELATED TOXIC EFFECTS WERE PAIN ALONG VEIN OF INJECTION AND ERYTHEMA OF SURROUNDING SKIN. MILD LEUKOPENIA AND REVERSIBLE GRADE 1 INCREASE IN LIVER FUNCTION WERE ALSO OBSERVED. ANTITUMOR ACTIVITY WAS NOT OBSERVED.
Dose amountVAR
Number1
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE